Copper-64 CMO for Clarity Pharmaceuticals

About Theragenics

Theragenics is a well-established, commercial-stage medical device company specializing in brachytherapy and radioisotope production. Its core business involves manufacturing low-dose-rate (LDR) brachytherapy seeds (e.g., TheraSeed Pd-103, AgX100 I-125, Cs-131) and operating a significant radioisotope contract manufacturing organization (CMO) facility. With a 40+ year history, the company serves the global oncology market by providing critical components for localized cancer treatment and enabling the development of novel radiopharmaceuticals for partners. Its integrated model from isotope production to finished device positions it as a key infrastructure player in the targeted radiotherapy space.

Therapeutic Areas